Skin and diabetes mellitus: what do we know?

被引:45
|
作者
Quondamatteo, Fabio [1 ]
机构
[1] NUI Galway, Skin & ECM Res Grp Anat, Galway, Ireland
关键词
Non-complicated skin; Diabetes mellitus; Cutaneous structure; Molecular composition; Diabetic skin; OPTICAL COHERENCE TOMOGRAPHY; STRATUM-CORNEUM BARRIER; EXTRACELLULAR-MATRIX; MAILLARD REACTION; OXIDATIVE STRESS; ANIMAL-MODELS; IN-VIVO; BULLOSIS DIABETICORUM; POSSIBLE INVOLVEMENT; ELECTRON-MICROSCOPY;
D O I
10.1007/s00441-013-1751-2
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Diabetes mellitus (DM) is becoming increasingly prevalent worldwide. Although major complications of this condition involve kidney, retina and peripheral nerves, the skin of diabetic patients is also frequently injured. Hence, interest is mounting in the definition of the structural and molecular profile of non-complicated diabetic skin, i.e., before injuries occur. Most of the available knowledge in this area has been obtained relatively recently and, in part, derives from various diabetic animal models. These include both insulin-dependent and insulin-resistant models. Structural work in human diabetic skin has also been carried out by means of tissue samples or of non-invasive methods. Indications have indeed been found for molecular/structural changes in diabetic skin. However, the overall picture that emerges is heterogeneous, incomplete and often contradictory and many questions remain unanswered. This review aims to detail, as much as possible, the various pieces of current knowledge in a systematic and synoptic manner. This should aid the identification of areas in which key questions are still open and more research is needed. A comprehensive understanding of this field could help in determining molecular targets for the prevention and treatment of skin injuries in DM and markers for the monitoring of cutaneous and systemic aspects of the disease. Additionally, with the increasing development of non-invasive optics-based deep-tissue-imaging diagnostic technologies, precise knowledge of cutaneous texture and molecular structure becomes an important pre-requisite for the use of such methods in diabetic patients.
引用
收藏
页码:1 / 21
页数:21
相关论文
共 50 条
  • [1] Skin and diabetes mellitus: what do we know?
    Fabio Quondamatteo
    Cell and Tissue Research, 2014, 355 : 1 - 21
  • [2] Chikungunya and diabetes, what do we know?
    de Almeida Barreto, Francisca Kalline
    Montenegro, Renan Magalhaes, Jr.
    Fernandes, Virginia Oliveira
    Oliveira, Rhaquel
    de Araujo Batista, Livia Aline
    Hussain, Akhtar
    de Goes Cavalcanti, Luciano Pamplona
    DIABETOLOGY & METABOLIC SYNDROME, 2018, 10
  • [3] Chikungunya and diabetes, what do we know?
    Francisca Kalline de Almeida Barreto
    Renan Magalhães Montenegro
    Virginia Oliveira Fernandes
    Rhaquel Oliveira
    Lívia Aline de Araújo Batista
    Akhtar Hussain
    Luciano Pamplona de Góes Cavalcanti
    Diabetology & Metabolic Syndrome, 10
  • [4] What Do We Know and We Do Not Know About Cardiovascular Autonomic Neuropathy in Diabetes
    Pop-Busui, Rodica
    JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2012, 5 (04) : 463 - 478
  • [5] What Do We Know and We Do Not Know About Cardiovascular Autonomic Neuropathy in Diabetes
    Rodica Pop-Busui
    Journal of Cardiovascular Translational Research, 2012, 5 : 463 - 478
  • [6] Managing tuberculosis in patients with diabetes mellitus: why we care and what we know
    Jeon, Christie Y.
    Murray, Megan B.
    Baker, Meghan A.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2012, 10 (08) : 863 - 868
  • [7] Diagnosis and therapy of functional disorders of the bladder in persons with diabetes mellitus. What do we actually know?
    Pannek, J.
    UROLOGE, 2010, 49 (03): : 381 - 386
  • [8] Turnover of human villous trophoblast in normal pregnancy: What do we know and what do we need to know?
    Mayhew, T. M.
    PLACENTA, 2014, 35 (04) : 229 - 240
  • [9] Diabetes mellitus: what the neurologists need to know
    Stephens, Jeffrey Wayne
    Williams, David M.
    Chudleigh, Richard
    PRACTICAL NEUROLOGY, 2022, 22 (06) : 532 - 539
  • [10] Type II Diabetes Mellitus and Endothelial Dysfunction: What Can We Do?
    Merdler, Ilan
    Arbel, Yaron
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2021, 23 (02): : 121 - 122